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Abstract
Background: Remote measurement technologies (RMT) can be used to collect data on a variety of bio-behavioral variables,
which may improve the care of patients with central nervous system disorders. Although various studies have explored their
potential, prior work has highlighted a knowledge gap in health care professionals’ (HCPs) perceptions of the value of RMT in
clinical practice.
Objective: This study aims to understand HCPs’ perspectives on using RMT in health care practice for the care of patients with
depression, epilepsy, or multiple sclerosis (MS).
Methods: Semistructured interviews were conducted with 26 multidisciplinary primary and secondary care HCPs who care for
patients with epilepsy, depression, or MS. Interviews were transcribed verbatim and analyzed using thematic analysis.
Results: A total of 8 main themes emerged from the analysis: (1) potential clinical value of RMT data; (2) when to use RMT
in care pathways; (3) roles of health care staff who may use RMT data; (4) presentation and accessibility of data; (5) obstacles
to successful use of RMT; (6) limits to the role of RMT; (7) empowering patients; and (8) considerations around alert-based
systems.
Conclusions: RMT could add value to the system of care for patients with central nervous system disorders by providing
clinicians with graphic summaries of data in the patient record. Barriers of both technical and human nature should be considered
when using these technologies, as should the limits to the benefits they can offer.
(J Med Internet Res 2020;22(7):e17414) doi: 10.2196/17414
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Introduction
Background
In a health care context, remote measurement technologies
(RMT) can be used by health care professionals (HCPs) and
clinical teams to collect data on a patient’s health or behavior
and use this to inform clinical decision making. The benefits of
RMT have been explored in the management of patients with
cardiac conditions [1-3], early stage dementia [4], neurological
disease [5], and attention deficit hyperactivity disorder [6] as
well as in behavior change [7] and monitoring for indicators of
sepsis [8] among others.
The European Union H2020 Remote Assessment of Disease
and Relapse-Central Nervous System (RADAR-CNS) project
[9] explores the use of RMT in the care of patients with epilepsy,
depression, or multiple sclerosis (MS). These conditions were
chosen for this project as exemplars of central nervous system
disorders that are under-researched in relation to RMT. As part
of this project, RADAR-base, a cloud-based platform, is being
developed to explore the potential to receive data from patients’
RMT and to provide these data to HCPs with a view to
informing clinical decision making [10]. This study is part of
this project, aiming to understand the clinical utility of RMT in
the care of patients with epilepsy, depression, or MS.
Previous literature has demonstrated the benefits of using RMT
in health care practice. A 2013 literature review of the use of
RMT in cardiology identified a number of studies demonstrating
reduced hospital visits in terms of both emergency and routine
appointments, as well as higher survival rates, in patients who
were monitored using RMT [11]. Benefits were also found in
patients’ relations with the care team, quality of life, and
compliance with treatments. However, no quality appraisal was
conducted in this narrative review.
Some studies have challenged these findings, suggesting little
or no evidence of an effect of RMT on key outcomes [12,13].
Other work has highlighted a number of barriers to
implementing RMT in health care practice. Erdmier et al [14]
described a lack of regulatory control over wearables as well
as a number of barriers to progress in implementation, including
technical capability, erratic user (patient) behavior, and a lack
of transparency from manufacturers. A patient and HCP-led
priority setting exercise in the field of digital mental health
highlighted the need to explore the impact of removing
face-to-face human interaction in care pathways for mental
health conditions, and raised issues of safety, effectiveness,
evaluation, and inequalities [15]. These issues apply equally to
the use of RMT.
Objectives
Authors of prior work in the area of RMT highlighted a need
for research to investigate the value to HCPs of implementing
RMT [13]. Davis et al [16] conducted a systematic review of
health care staffs’ views on the use of RMT in clinical practice
and included 15 relevant studies. They concluded that “there is
a critical need to engage end-users in the development and
implementation of RMT” and highlighted that the evidence base
in this area is small. This paper seeks to address these points
by exploring HCPs’perspectives on the implementation of RMT
in three central nervous system disorders.
Methods
Aim
This study aims to understand the perspectives of HCPs on the
use of RMT in health care practice for the care of patients with
depression, epilepsy, or MS.
Recruitment
We purposively recruited a sample of 26 HCPs, with the
intention of covering multiple clinical roles (with representation
from medical, nursing, and allied health professionals).
Participants were all working in the National Health Service
(NHS) in England in the care of patients with epilepsy,
depression, or MS or a combination of these conditions.
Participants were contacted through the professional networks
of the research team members.
Procedure
A semistructured interview approach was used, with interviews
lasting from 16 to 56 min (mean 30 min). An interview schedule
was used to guide questioning, with ad hoc follow-up questions
used to further explore salient points. Participants gave informed
consent and were incentivized with a £15 (US $18) charity
donation.
A total of 23 interviews were conducted one to one, whereas
one interview was conducted with three participants together.
Moreover, 13 interviews were conducted by phone, whereas 11
were conducted in person. All interviews were recorded from
start to finish using a voice recorder. The study was approved
by the University of Nottingham School of Medicine research
ethics committee (ref 277-1802).
Analysis
Interviews were transcribed verbatim and analyzed using
thematic analysis [17]. Data were coded and themed (by JA)
using NVivo 12 (QSR International). Initial codes and themes
were discussed within the research team and were iteratively
renamed and reformed throughout the analysis process. No new
themes emerged when the last interview was coded, and so, it
is considered that the sample reached data saturation.
Results
Participants
Participants were HCPs (medical doctors, nurses, clinical
psychologists, physiotherapists, and dietitians) from 13 NHS
trusts (health care organizations) within England. Of the 26
participants, 8 (31%) were female. A total of 12 participants
specialized in the care of patients with epilepsy, 6 in depression,
6 in MS, and 2 were general practitioners working across all 3
conditions. Participants included both primary and secondary
care clinicians. Moreover, 13 of the 26 interviewees had used
RMT with their patients, and 14 of the 26 said that their patients
had brought data to appointments. The health care roles of the
participants are presented in Table 1 along with their
specialization and gender.
J Med Internet Res 2020 | vol. 22 | iss. 7 | e17414 | p. 2https://www.jmir.org/2020/7/e17414
(page number not for citation purposes)
Andrews et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Table 1. Job roles, genders, and specializations of interview participants.
Total (N=26)Generalist (n=2)Multiple sclerosis (n=6)Epilepsy (n=12)Depression (n=6)Clinical specialization
8 (30)1 (50)2 (33)4 (33)1 (17)Gender (female), n (%)
Job role
4 (15)0 (0)0 (0)0 (0)4 (67)Psychiatrist
3 (12)0 (0)2 (33)0 (0)1 (17)Psychologist
9 (35)0 (0)3 (50)6 (50)0 (0)Neurologist
1 (4)0 (0)0 (0)1 (8)0 (0)Dietician
5 (19)0 (0)0 (0)4 (33)1 (17)Specialist nurse
1 (4)0 (0)1 (17)0 (0)0 (0)Physiotherapist
3 (12)2 (100)0 (0)1 (8)0 (0)General practitioner
Thematic Analysis
Our analysis generated 8 main themes, each of which also
featured a number of subthemes.
Theme 1: Potential Clinical Value of the Remote
Measurement Data
The interviews explored the types of physiological,
psychosocial, and lifestyle variables that could be targets for
measurement using RMT. The HCPs described uses for certain
variables they considered to be potentially useful in the care of
patients with 1 of the 3 conditions. Variables considered by
participants to hold potential are summarized in Table 2.
Table 2. Target variables considered potentially useful to measure using remote measurement technology.
VariableCondition
Activity, anxiety, cognition, dieta, heart rateb, mood, quality of life, seizures (or proxies thereof), and sleepEpilepsy
Activity, anxiety, diet, mood, relapse signatures, sleep, and weightDepression
Activity, anxiety, cognition, fatigue, mood, pain, quality of life, and visual acuityMultiple sclerosis
aOpposing views on the value of measuring diet were offered by different participants.
bIt was noted that heart rate would be worth measuring in epilepsy only if proven to be a proxy measure of seizures.
Epilepsy
Participants stated that it would be useful to collect data from
RMT that could indicate the occurrence of a seizure or number
of seizures, especially in those who have many. However,
participants thought that the current approaches to seizure
detection (eg, Empatica and Embrace) were limited by lack of
sensitivity to detect the full range of seizure types:
The limitations of this particular device is that it is
designed for detecting repetitive movements which is
of use for tonic clonic seizures, however, there are
different types of seizures which definitely don’t all
involve movement but are still epileptic so they
wouldn’t be able to detect that [...] It would be ideal
to have something where all types of seizures would
be recorded. [P02]
Several types of RMT data were mentioned by participants as
possible proxy measures of seizures. These were skin
conductance, heart rate, accelerometry, pressure sensor readings,
and electroencephalography. There were differing views on the
usefulness of measuring heart rate and bed pressure as proxy
measures for seizures, given the possibility of false positive
signals (ie, lack of specificity).
Video and audio may be utilized remotely to assist with
diagnosis and seizure identification, particularly through
measurement of the sound and duration of a seizure:
I will sometimes tell people who struggle to video
their loved one in a seizure for whatever reason, just
to start the video going, put the phone down, and then
it will both record the sound, and the duration of the
seizure, which are probably the two most useful things
we need, outside of seeing one. [P09]
Depression
Activity data, including movement and GPS, were thought to
be useful in detecting whether a patient was “leaving the house”
[P21] or “getting out and about” [P06], which in turn could be
considered a potential “proxy marker of depression severity”
[P16]. This was also thought to have the potential to indicate a
patient’s global level of functioning. RMT data were also
thought to offer a level of objectivity in the measurement of
depression, which was otherwise lacking. Prospective mood
monitoring using an electronic diary and measurement of sleep
using wearables were also mentioned as potentially helpful in
managing depression, where currently, systems such as Fitbits
and mood diary apps could not collate this information together
automatically.
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Multiple Sclerosis
Participants saw potential in the use of RMT to measure fatigue,
via a self-report app, and also cognition, given its association
with relapse. However, some considered it difficult to pick one
particular aspect of MS to measure using RMT because the
symptoms experienced by patients vary:
I don’t think you can have a particular tool that you
would need to use for everyone. I think it is largely
going to be dependent on the symptom profile. [P20]
Multiple participants mentioned visual acuity as an important
indicator of relapse, which could be measured using RMT,
although they were unsure if technology would be able to
measure it when even well-trained humans struggled:
It would have to be really well designed to pick up
those intricacies [...] sometimes it is really difficult
even for the neurologist to say this person is having
a relapse or they are not. [P19]
Theme 2: When to Use Remote Measurement
Technology in the Care Pathway
Participants described different points in care pathways when
data from RMT could usefully inform the care of their patients.
Figures 1-3 demonstrate where participants indicated that it
could be useful to receive data from RMT. Clinicians indicated
that they would like data collected via RMT to be readily
accessible in their electronic patient records (EPRs) when
patients attended for appointments.
Figure 1. Participants’ comments about the timing of the use of remote measurement technology in the epilepsy care pathway, including monitoring
on a yearly basis once stable to allow assessment of follow-up and to create data for future research.
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Figure 2. Participants’ comments about the timing of the use of remote measurement technology in the depression care pathway, including monitoring
during a change in treatment.
Figure 3. Participants’ comments about the timing of the use of remote measurement technology in the multiple sclerosis care pathway, indicating the
benefits of monitoring for a short period before an appointment.
It is acknowledged that not every patient’s journey along a care
pathway follows the same trajectory. These figures are for
illustrative purposes only.
Theme 3: Roles of Health Care Staff Who May Use
Remote Measurement Technology Data.
Participants discussed the roles of health care staff who should
be involved in using any RMT data. Across all 3 conditions,
participants suggested that primary care was a good place for
data to be managed, given the systems available:
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Primary care is certainly quite well set up with
systems in place to action on things based through
the electronic patient record. [P06]
In secondary care, specialist nurses were considered to have the
closest relationships with patients among members of the care
team, and thus, they were suggested to be the team member
most likely to review data from RMT. For example, in epilepsy:
If it’s sort of data that is being in some way
downloaded in between clinics, then there would
certainly be a role for something like an epilepsy
nurse to look at that data. [P09]
Participants considered it important that all clinical, but not
administrative, members of a team involved in the treatment of
a patient should have access to RMT data when it is collected:
The discussions we’ve had are about, is it appropriate
for admin staff to review that or actually does it have
to be a clinician from a risk perspective [...] Your
economic arguments come in about experienced
clinicians are too expensive but I think making the
wrong triage decision is also too expensive. [P21]
Theme 4: Presentation and Accessibility of the Remote
Measurement Technology Data
Participants had a variety of views on the best way for data to
be presented to them. Particular emphasis was placed on the
importance of interoperability and the ability for any data from
RMT to be accessible within an existing EPR system rather
than requiring the opening of another window or program:
If [...] you want to have the information available to
you at times other than when your patient is there,
then it would be good if it could feed directly into
your electronic patient record. [P07]
Across all 3 conditions, HCPs were keen to have data aggregated
in a visual or graphical format. Some also recalled instances
where they had used devices or software that presented
information in graphs automatically and commented that this
was useful for the patient as well as for the clinician:
For most of them [mood-reporting apps] you can do
a graph function so they can show you the whole three
months, in a fairly small chart, which helps us to think
about if there have been any stresses or life events
that have changed their mood or whether there’s a
pattern to the time of day, and so on. [P07]
The speed of access to information was also considered to be a
priority. Participants spoke of particular situations in which the
use of digital records could increase efficiency through time
saving:
I certainly think if you can access the information
quickly then it could be a focus point for the whole
consultation and it could speed things up. [P16]
Uploading data to the EPR was considered preferable to
reviewing data that patients brought to the clinic on their mobile
phones:
It could be sent in and loaded up in the patients notes
or some other big screen device otherwise you are
kind of stuck with little handheld mobiles and it’s not
really that helpful. [P13]
Theme 5: Obstacles to the Successful Use of Remote
Measurement Technologies
Participants mentioned several aspects of the use of RMT, which
they considered to be obstacles to their successful use and
adoption in practice. These fitted into 2 broad categories of
technical issues and human issues.
The most frequently mentioned technical issue was data
accuracy (“I’m not sure they’re accurate.” [P03]). However,
participants indicated that they would be happy to use devices
even when they provided data that were not 100% accurate, so
long as the clinician was aware of the margins of error that the
data may contain:
So being as clear as possible what the potential
pitfalls might be about all the data that we get back
[...] I think as long as you know, kind of where it
might go wrong, or how to be careful which bits to
not over-interpret, then I think it’s fine [P09]
There was also concern about the interoperability of any new
system with existing ones, as clinicians are already required to
use several different software packages to manage patients:
The main trouble currently is a lack of integration.
[P01]
Data security was also discussed as an important issue to
consider, although participants had differing views on the level
of risk that providing data remotely may entail. Some had
concerns:
Who has access to this data? Including if they have
it on their phone, what if their phone goes missing,
where does this data go? There’s a big, data
protection bit, there’s a big big, patient safety bit.
[P03]
Some advocated taking a pragmatic approach to reduce risk
while continuing to use technology where it provided a benefit:
I think as long as appropriate safeguards are taken
then that’s fine, and I think sometimes this can be a
barrier, an unnecessary barrier to introducing things
that can be helpful. [P06]
Human issues considered obstacles to the use of RMT largely
focused on 2 areas: patient anxiety and patient motivation.
Participants discussed ways in which the use of RMT may cause
patient anxiety through over focusing on their symptoms and
how this in turn could be problematic for a health service:
We have had quite a few patients coming in that have
used these monitoring devices and say my heart rate
is really fast. For them it’s another layer of education
so it actually creates us more work. [P03]
However, others were less concerned, believing that RMT would
not induce anxiety in patients who were not prone to it in the
first place or that any anxiety would be manageable:
J Med Internet Res 2020 | vol. 22 | iss. 7 | e17414 | p. 6https://www.jmir.org/2020/7/e17414
(page number not for citation purposes)
Andrews et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
We’ve always found ways to react to that anxiety, this
is just what it looks like in the current generation.
[P21]
Participants suggested that patients with depression would have
less motivation to engage with RMT as a result of their
condition:
A lot of our patients may, especially if they’re more
severely depressed, not be very motivated to interact
with the app [P16]
However, the use of RMT to generate more objective evidence
of a patient’s health state was considered by some to be useful
in motivating engagement with their care:
So if you do your usual interview and you’ve got
objective evidence to say, I think your depression is
coming back or you haven’t been exercising enough
or you have way more seizures than you think, then
of course, that might help motivating them to do
certain things. [P22]
Theme 6: Limits to the Role of Remote Measurement
Technology
Several of our participants mentioned elements of care in their
specialism, which, in their view, should not be replaced by an
RMT-enabled approach. In MS, the importance of face-to-face
appointments was highlighted as essential for HCPs to identify
subtle signs of worsening condition:
You really need to be physically examining the patient
as well as hearing their perspective because there’s
subtle deficits that you can pick up on at examination
that people won’t notice day to day [...] you can pick
up things like subtle signs like nystagmus, or problems
with the balance or things like that, that people often
won’t notice. [P01]
In epilepsy too, HCPs reiterated the importance of seeing their
patients face to face:
If their seizure frequency has increased you’re there
thinking I probably need to see you, what else is going
on? Have they got a cold, a water infection? Is there
something else going on in their life? Are they not
taking their tablets? Sometimes some of those
conversations need to be had. [P03]
A general practitioner mentioned the relational side of their
work as important in the care of patients with depression:
The relationship element of it is very important, and
obviously in primary care a lot of what I’m thinking
is around depression [...] the human to human contact
with someone who’s struggling with mood, and the
fact that you’ve got someone who can be empathic
and rapport rather than just crunching data. [P06]
Theme 7: Empowering Patients
HCPs believed that RMT may benefit patients because it might
empower them to take a leading role in their care. Some
clinicians believe that patients should lead the use of technology
and, therefore, have more control over their own care:
The way I see it is it’s more about the patient using
the data for themselves, the clinician is almost the
passive recipient of the data who is working with the
patient to try and interpret it and help them develop
techniques to use the data themselves. [P07]
HCPs also spoke of how patients could be given full control of
their own data collected using RMT and allow those data to be
shared with a chosen clinician when they deemed it necessary:
Within the patient held database, [...] presumably a
sort of secure log in, and that is, it’s
patient-controlled [...] and they could give out the
ability to share. [P15]
Participants provided examples of how a patient could be
empowered through the use of RMT, by determining when to
arrange an appointment based on the outputs from the
technology:
Through prospective mood monitoring you could
capture periods where there had been a persistent
lowering of mood over two weeks or more with
associated other features or even shorter periods than
that, that you’d agreed as part of a relapse signature.
What people could do in those instances is potentially
bring appointments forward. [P13]
However, in the case of depression, participants saw difficulties
with patient motivation and thus thought it would be unlikely
that patients would be able to take control of their own care:
[That] involves them taking a lot of responsibility for
their own healthcare and I guess that may work better
in some conditions, more than depression. [P16]
For some, it was a case of providing care on an individual basis:
I would tailor it to what they wanted, so you will have
those who are very tech savvy who don’t have any
time and think this will really suit me, others are very
much I really want to see you doctor [...] the key is
to listen to them and individualise care rather than
doing tick box medicine which we sometimes do. [P03]
Theme 8: Alert-Based Systems
There was debate across all 3 conditions in the interviews about
the potential to use RMT to alert clinicians when a monitoring
variable fell outside normative parameters, for example, if
seizures increased in severity or frequency, if mood or activity
were found to be particularly low, or if fatigue increased. The
majority of participants considered such a system to be
beneficial, so that interventions could be put in place as soon
as possible:
It would be a system that had parameters set and
triggered active alerts when those parameters were
exceeded, I think would be the only way that I could
see a lot of our consultant body engaging in it. [P01]
However, a small number of participants thought that such a
system would be problematic, principally because alerts may
create excessive demand for immediate processing,
interpretation, and response (eg, outside of normal working
J Med Internet Res 2020 | vol. 22 | iss. 7 | e17414 | p. 7https://www.jmir.org/2020/7/e17414
(page number not for citation purposes)
Andrews et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
hours), and there would not be enough health care staff available
to respond to the alerts produced:
Outside of fixed appointments the question would be
who would actually have time and headspace to
actually look at what was being flagged up. You would
need to really carefully think about the staffing in the
NHS and mental health services. [P13]
HCPs also perceived there to be a risk that alerts would go
unnoticed in the system:
My worry is this data arrives and nobody looks at it
for weeks, it’s sitting somewhere in the ether. [P03]
Several participants suggested that it would be more useful if
the technology alerted the patient to take action through their
regular treatment pathways, rather than putting the onus on the
clinician:
I would want it to prompt the patient to make contact
with me. [P14]
Some saw a need for further research to determine the benefits
of an alert-based system:
Unless you could do a good study and demonstrate
that sending me alerts from an automated app would
be helpful, then I would just want information that I
could look back on when I next met with a patient
face to face. [P14]
Discussion
Principal Findings
A total of 8 themes emerged from the analysis of our interviews.
The first theme covered the potential clinical value of the remote
measurement data. Where RMT are currently used in health
care practice, HCPs find them to be largely inaccurate,
particularly in the case of epilepsy, although efforts to develop
more effective ways of monitoring epilepsy are welcomed.
Participants were optimistic about the future use of activity data
to monitor symptoms of depression and considered that using
RMT to collect measures of fatigue and cognition in patients
with MS would be useful.
In theme 2, key points in care pathways for the 3 conditions
were identified as times where RMT data could provide most
value. These included monitoring a short period before an
appointment (MS), monitoring during a change in treatment
(epilepsy), and monitoring on a regular basis once a patient was
in a stable condition, to allow assessment of follow-up and to
create data for future research (depression, epilepsy, and MS).
The third theme considered staff roles in the management of
RMT use by patients. Participants suggested that all staff
involved in a patient’s care should have easy access to data
generated by RMT via the patient record. Participants also made
it clear that triage using data from RMT should be conducted
by qualified HCPs rather than by administration staff. Primary
care staff and specialist nurses in secondary care were thought
to be well placed to manage incoming data from patients.
With regard to the presentation of data, in theme 4, HCPs
described ease and speed of access to RMT data to be important
for their successful use and emphasized the importance of
interoperability with the patient record. Presentation of data in
graphs was mentioned as helpful for interpretation.
Theme 5 discussed obstacles to the successful use of RMT, and
these included both technical issues such as data accuracy and
data security (where views differed on the risks involved) and
human issues such as anxiety created by monitoring (although
not all participants agreed that this was an issue).
In theme 6 on the limits of RMT benefit, participants
emphasized that RMT would never completely replace
face-to-face appointments, particularly in depression where
relationships were considered important.
The seventh theme concerned patient empowerment. HCPs
expressed the value in providing patients access to their own
data, enabling them to take an active role in their own care, for
example, by advancing appointments where RMT data indicated
it was necessary. However, there was some concern about
patients with depression having the motivation to take
responsibility for their own care.
Theme 8 was related to alert-based systems. Participants debated
the value of such systems and highlighted the requirements for
their successful use. Some thought alerts should be used to invite
the patient to take action rather than alerting a clinician, due to
workload concerns. The need for further research to determine
the benefits of alert-based systems was also highlighted.
Comparison With Prior Work
Although prior work exploring RMT in health care has
principally identified benefits and barriers to its implementation
[11,14], this study has investigated HCPs’ perceptions of the
clinical value of implementing RMT, helping to address the
knowledge gap identified by Vegesna et al [13] and Davis et al
[16].
The themes emerging in this study add to findings from prior
work in this area. Our findings support the work of Bruno et al
[18], who highlighted that HCPs may view the management of
data from digital devices as a burden. Goodrich et al [19], among
others, have highlighted the importance of interoperability and
a preference for data from mobile technologies to be
automatically integrated into clinical records, similar to the
views of our participants. Clinicians’ concern about the need
to respond to alert-based systems has also been raised previously
[16,20].
Prior work has also emphasized the importance of face-to-face
contact in the context of digital technology and mental health
care [21]. A priority setting exercise for digital mental health
[15] identified the need to explore the impact of removing such
interactions from care pathways. Our data have shown that
HCPs view face-to-face appointments as essential in the care
of patients with these 3 conditions, even where RMT could
provide them with detailed recent data on a patient’s status. Our
data show that HCPs imagine patients could be empowered to
determine their own need for a clinical appointment based on
data from RMT, helping to address questions around the impact
of technology on access to services, which has also been
identified as a research priority [15].
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Davis’Technology Acceptance Model [22] describes perceived
usefulness and perceived ease of use as key mediators to the
successful uptake of a new technology. Our analysis highlights
ways in which clinicians perceive RMT data could be useful
(theme 1) as well as where there are limits or obstacles to this
usefulness (themes 5 and 6). We have also identified how speed
and ease of access to data are desirable for HCPs (theme 4),
evidencing how perceived ease of use is applicable to this area.
The analysis also raises the tailoring of care for patients using
RMT (theme 7), where it was discussed that patients’perception
of RMT should be that it is both useful and easy to use to
motivate continued use.
Beyond the findings presented in previous work, our findings
specify the types of RMT data that clinicians would value in
the management of epilepsy, depression, and MS as well as the
points in patient care at which these data would be of most use
and the health care roles that would be best placed to manage
these data.
Implications for Researchers and Developers
Findings from these themes will help to inform the development
of the RADAR-CNS approach in the application of RMT for
better care for epilepsy, MS, and depression. Researchers and
companies developing monitoring technologies should ensure
that the boundaries of accuracy of any new solution are well
defined, such that clinicians can understand the level of
confidence they should place in readings from such devices. As
HCPs believe patients may benefit from the option to move or
advance appointments based on their data, it would also be
worthwhile for any mobile health solutions to link with
appointment planning services, so that these can be easily
accessed. In the United Kingdom, the NHS app is an example
of such a system.
Strengths and Limitations
This study has several strengths. We recruited a
multidisciplinary group of HCPs working in a variety of clinical
staff roles in primary and secondary care. Therefore, the use of
RMT was considered from multiple perspectives. The study
was limited in its consideration of only three specific central
nervous system disorders in one national health care system.
However, the analysis has considered how insights gained from
staff working in these three conditions might generalize and
has permitted a deeper analysis of the three conditions
mentioned. The ratio of male to female participants was high,
with only 8 of 26 participants being female. Epilepsy staff were
over-represented in comparison with depression and MS staff
due to the convenience sampling method. However, staff were
represented across most roles in the care team for each of the
three conditions represented, with the exception of MS, where
an MS nurse could not be recruited in the time available.
Future Directions
Although we have focused our consideration of the use of patient
RMT data on an individual basis, further work could usefully
explore the use of combined RMT data from groups of patients
to assess risk or identify trends. The 2019 Topol Review
highlighted the potential of integrating predictive analytics into
diagnosis and care pathways [23], and data from RMT could
feed into these approaches.
Future work should also explore the views of health service
managers, commissioners, and public health representatives to
understand the value that the implementation of RMT could
provide from a health care system payer and management
perspective, for example, in its potential to increase efficiencies
and improve outcomes for different patient populations.
Given the participants’views on the importance of nurses’ roles
in the management of patients’ use of RMT, it would be useful
to conduct further research to better understand nurses’ views
on subsuming associated responsibilities into their roles.
Although some work has explored nurses’ views on their roles
in the use of technology in intensive care situations [24] and
telehealth for diabetes [25], to our knowledge, no studies have
explored views specifically relating to RMT in central nervous
system disorders.
Further work should also be completed to understand how RMT
might best facilitate increased patient autonomy (as advocated
in the NHS Long Term Plan [26]) and situations where this may
be less appropriate or successful. The remote assessment of
disease and relapse-major depressive disorder study is recruiting
600 people with a major depressive disorder to use RMT over
a period of 2 years, and this study may shed light in this area
[27].
Conclusions
This paper has explored the views of HCPs on using RMT in
managing central nervous system disorders, specifically
epilepsy, MS, and depression. The results are as follows:
• target physiological variables for measurement that
clinicians believe would be useful
• points in care pathways at which clinicians perceive benefit
to patients using RMT
• roles of health care staff best placed to manage incoming
data
• HCPs’ preferred presentation of data
• obstacles to the successful implementation of RMT
• limits to the benefits that the RMT can provide
• ways in which patients may be empowered through the use
of RMT
• considerations around alert-based systems.
Our findings show the importance of early engagement and
co-design with HCPs when considering user requirements and
potential use cases before using RMT in clinical care pathways.
HCPs believe that RMT data can add value to the care of
patients with these three conditions but are not sufficient for
decisions about care to be made exclusively on the basis of these
data. We have demonstrated that clinicians are pragmatic about
the data security risks of using RMT data with patients. Further
research is required to establish how RMT data could be used
on a population level to benefit patients with central nervous
system disorders.
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